Epigenetic Mechanisms and Symptom Clusters Associated with Resolution of Pain Following Spinal Cord Stimulation

NCT04960592 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2024-09-03

No results posted yet for this study

Summary

Spinal cord stimulation (SCS) is indicated for selected patients with chronic pain who have not responded to conventional medical management.

Forty (40) patients indicated for SCS placement and presenting to the University of Arkansas for Medical Sciences (UAMS) Interventional Pain Management Clinic in Little Rock, Arkansas will be recruited for this study. Prior to temporary stimulator placement, patients will complete symptom-related questionnaires and provide a blood sample. Demographic and clinical characteristics will be obtained through medical record review. Patients will complete the same questionnaires and provide a blood sample at each of the routine clinical care follow-up visits.

Conditions

Interventions

DEVICE

Spinal Cord Stimulation

Temporary implantation of a clinical available neurostimulator.

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Kimberly Stephens, PhD · University of Arkansas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-15
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04960592 on ClinicalTrials.gov